LETTER TO THE EDITOR
p21 is necessary for the beneficial effects of fasting during chemotherapy
Adrián Plaza, Andrés Pastor-Fernández, José L. López-Aceituno, Marta Barradas, Cristina Pantoja, Pablo J. Fernandez-Marcos
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 11/4/2022 doi:10.1002/cac2.12384
ORIGINAL ARTICLE
circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer
Yufei Yang, Dakui Luo, Yang Shao, Zezhi Shan, Qi Liu, Junyong Weng, Weijing He, Ruoxin Zhang, Qingguo Li, Ziliang Wang, Xinxiang Li
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 11/3/2022 doi:10.1002/cac2.12380
REVIEW
Targeting RAS mutants in malignancies: successes, failures, and reasons for hope
Hang Yang, Xinyi Zhou, Dongliang Fu, Chenqin Le, Jiafeng Wang, Quan Zhou, Xiangrui Liu, Ying Yuan, Kefeng Ding, Qian Xiao
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/31/2022 doi:10.1002/cac2.12377
ORIGINAL ARTICLE
Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long-term clinical outcomes and health-related quality of life assessment
Chen-hua Yan, Yu Wang, Yu-qian Sun, Yi-fei Cheng, Xiao-dong Mo, Feng-rong Wang, Yu-hong Chen, Yuan-yuan Zhang, Ting-ting Han, Huan Chen, Lan-ping Xu, Xiao-hui Zhang, Kai-yan Liu, Xiao-jun Huang
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/23/2022 doi:10.1002/cac2.12376
REVIEW
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
Tongxin Ge, Xiang Gu, Renbing Jia, Shengfang Ge, Peiwei Chai, Ai Zhuang, Xianqun Fan
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/20/2022 doi:10.1002/cac2.12374
ORIGINAL ARTICLE
Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract
Huanwen Wu, Zicheng Yu, Yueping Liu, Lei Guo, Lianghong Teng, Lingchuan Guo, Li Liang, Jing Wang, Jie Gao, Ruiyu Li, Ling Yang, Xiu Nie, Dan Su, Zhiyong Liang
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/20/2022 doi:10.1002/cac2.12372
REVIEW
The diagnosis, classification, and treatment of sarcoma in this era of artificial intelligence and immunotherapy
Amandine Crombé, Mathtieu Roulleau-Dugage, Antoine Italiano
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/19/2022 doi:10.1002/cac2.12373
LETTER TO THE EDITOR
Social-epigenetic mediators for racial disparities in pulmonary impairment among childhood cancer survivors
Nan Song, Qian Dong, Cheng Chen, Qian Li, Heather Mulder, Emily Plyler, John Easton, Emily Walker, Scott Olson, Geoffrey Neale, Kevin R. Krull, Deo Kumar Srivastava, Kirsten K. Ness, Jinghui Zhang, Melissa M. Hudson, Leslie L. Robison, I-Chan Huang, Zhaoming Wang
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/18/2022 doi:10.1002/cac2.12371
LETTER TO THE EDITOR
Malignant transformation by oncogenic K-ras requires IDH2-mediated reductive carboxylation to promote glutamine utilization
Rui Liu, Panpan Liu, Huichang Bi, Jianhua Ling, Huiqin Zhang, Mingquan Zhang, Yumin Hu, Paul J Chiao, Peng Huang, Jinyun Liu
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/17/2022 doi:10.1002/cac2.12369
LETTER TO THE EDITOR
Cell models with inducible oncogenic translocations allow to evaluate the potential of drugs to favor secondary translocations
Anna Shmakova, Nikolai Lomov, Vladimir Viushkov, Tatyana Tsfasman, Yana Kozhevnikova, Darina Sokolova, Vadim Pokrovsky, Marina Syrkina, Diego Germini, Mikhail Rubtsov, Yegor Vassetzky
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/17/2022 doi:10.1002/cac2.12370
